Wegovy 1 mg FlexTouch Pen contains Semaglutide, used for weight management in adults with obesity. It helps control appetite, reduce calorie intake, and support long-term weight loss under medical supervision.
$450.00
SKU: N/A
Categories: Diabetes Care, Diabetes Type 2, Weight Loss
Introduction
Wegovy 1 mg FlexTouch Pen is among the first-line treatments for weight loss among overweight or obese adults. It is an effective formulation of Semaglutide for helping the users lose weight safely, reduce the risk of associated health risks (like cardiovascular events, organ failure, etc), prevent weight regain for the long term, and lead an improved quality of life. This medication has minimal side effects but works as desired only if combined with a balanced diet and regular exercise.
This Semaglutide 1 mg pen by Novo Nordisk India is known for delivering promising results with responsible use and regular health monitoring. Consult your doctor today for a custom treatment plan for weight loss and obesity management with Wegovy.
What is Wegovy 1 mg FlexTouch pen (Semaglutide)?
Wegovy 1 mg Pen is a self-injectable Semaglutide pen for weight loss in people diagnosed as overweight or obese. It is formerly prescribed for treating Type-2 diabetes among adults, but its benefits for making the users lose